| Sandu Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524703 |
NSE Symbol : - |
P/E(TTM) : 16.25 |
|
ISIN Demat : INE751D01014 |
Div & Yield% : 2.32 |
EPS(TTM) : 2.12 |
|
Book Value(₹) : 34.85 |
Market Cap(₹Cr) : 33.29 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 18.76 | 17.62 | 16.70 | 14.07 | 18.37 | 17.70 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 18.76 | 17.62 | 16.70 | 14.07 | 18.37 | 17.70 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 0.05 | 0.02 | 0.07 | 0.02 | 0.03 |
| Total Income | 18.77 | 17.67 | 16.72 | 14.14 | 18.40 | 17.73 |
| Total Expenditure | 17.72 | 16.76 | 16.17 | 13.62 | 17.38 | 16.79 |
| PBIDT | 1.05 | 0.91 | 0.54 | 0.52 | 1.02 | 0.95 |
| Interest | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| PBDT | 1.02 | 0.88 | 0.52 | 0.49 | 0.99 | 0.92 |
| Depreciation | 0.17 | 0.17 | 0.18 | 0.15 | 0.19 | 0.17 |
| Tax | -0.05 | 0.20 | 0.10 | 0.07 | 0.23 | 0.21 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.07 | -0.01 | 0.02 | -0.06 | 0.01 | 0.03 |
| Reported Profit After Tax | 0.98 | 0.52 | 0.22 | 0.33 | 0.56 | 0.50 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.98 | 0.52 | 0.22 | 0.33 | 0.56 | 0.50 |
| EPS (Unit Curr.) | 1.01 | 0.54 | 0.23 | 0.34 | 0.57 | 0.52 |
| EPS (Adj) (Unit Curr.) | 1.01 | 0.54 | 0.23 | 0.34 | 0.57 | 0.52 |
| Calculated EPS (Unit Curr.) | 1.01 | 0.54 | 0.23 | 0.34 | 0.57 | 0.52 |
| Calculated EPS (Adj) (Unit Curr.) | 1.01 | 0.54 | 0.23 | 0.34 | 0.57 | 0.52 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.04 | 2.17 | 0.92 | 1.35 | 2.30 | 2.07 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.04 | 2.17 | 0.92 | 1.35 | 2.30 | 2.07 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 |
| Reserve & Surplus | 0.00 | 32.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 5.60 | 5.16 | 3.23 | 3.70 | 5.55 | 5.37 |
| PBDTM(%) | 5.44 | 4.99 | 3.11 | 3.48 | 5.39 | 5.20 |
| PATM(%) | 5.22 | 2.95 | 1.32 | 2.35 | 3.05 | 2.82 |
